These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20534814)

  • 101. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
    Wansleben S; Davis E; Peres J; Prince S
    Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
    [TBL] [Abstract][Full Text] [Related]  

  • 102. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
    Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
    Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
    [TBL] [Abstract][Full Text] [Related]  

  • 103. TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.
    Lv Y; Si M; Chen N; Li Y; Ma X; Yang H; Zhang L; Zhu H; Xu GY; Wu GP; Cao C
    Oncotarget; 2017 Aug; 8(32):52699-52707. PubMed ID: 28881763
    [TBL] [Abstract][Full Text] [Related]  

  • 104. TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.
    Liu X; Miao Z; Wang Z; Zhao T; Xu Y; Song Y; Huang J; Zhang J; Xu H; Wu J; Xu H
    Exp Ther Med; 2019 Jan; 17(1):723-729. PubMed ID: 30651856
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Epigenetic Suppression of the T-box Subfamily 2 (
    Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A Cautious Note on Thalidomide Usage in Cancer Treatment: Genetic Profiling of the TBX2 Sub-Family Gene Expression is Required.
    Nemer G; Khalil A
    Drug Res (Stuttg); 2019 Sep; 69(9):512-518. PubMed ID: 30934098
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Regulation of otocyst patterning by Tbx2 and Tbx3 is required for inner ear morphogenesis in the mouse.
    Kaiser M; Wojahn I; Rudat C; Lüdtke TH; Christoffels VM; Moon A; Kispert A; Trowe MO
    Development; 2021 Apr; 148(8):. PubMed ID: 33795231
    [TBL] [Abstract][Full Text] [Related]  

  • 108. TBX2-positive cells represent a multi-potent mesenchymal progenitor pool in the developing lung.
    Wojahn I; Lüdtke TH; Christoffels VM; Trowe MO; Kispert A
    Respir Res; 2019 Dec; 20(1):292. PubMed ID: 31870435
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins.
    Sahm BDB; Peres J; Rezende-Teixeira P; Santos EA; Branco PC; Bauermeister A; Kimani S; Moreira EA; Bisi-Alves R; Bellis C; Mlaza M; Jimenez PC; Lopes NP; Machado-Santelli GM; Prince S; Costa-Lotufo LV
    Front Chem; 2020; 8():110. PubMed ID: 32195221
    [TBL] [Abstract][Full Text] [Related]  

  • 110. TBX2 Expression predicts Tumor Recurrence and Adjuvant Chemotherapy Benefits in Gastric Cancer Patients following R0 Resection: a proposed approach for risk stratification.
    Lu J; Xu Y; Wang YH; Huang XY; Wu Y; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
    J Cancer; 2020; 11(11):3172-3179. PubMed ID: 32231721
    [No Abstract]   [Full Text] [Related]  

  • 111. MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme.
    Pan CM; Chan KH; Chen CH; Jan CI; Liu MC; Lin CM; Cho DY; Tsai WC; Chu YT; Cheng CH; Chuang HY; Chiu SC
    Cancer Lett; 2020 Nov; 493():133-142. PubMed ID: 32861705
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
    Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
    Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
    [TBL] [Abstract][Full Text] [Related]  

  • 113. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
    McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
    Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
    [TBL] [Abstract][Full Text] [Related]  

  • 114. TBX2 controls a proproliferative gene expression program in melanoma.
    Lu S; Louphrasitthiphol P; Goradia N; Lambert JP; Schmidt J; Chauhan J; Rughani MG; Larue L; Wilmanns M; Goding CR
    Genes Dev; 2021 Dec; 35(23-24):1657-1677. PubMed ID: 34819350
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The Evolution of Melanoma - Moving beyond Binary Models of Genetic Progression.
    Zeng H; Judson-Torres RL; Shain AH
    J Invest Dermatol; 2020 Feb; 140(2):291-297. PubMed ID: 31623932
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer's disease.
    Reinhardt S; Schuck F; Stoye N; Hartmann T; Grimm MOW; Pflugfelder G; Endres K
    Cell Mol Life Sci; 2019 Mar; 76(5):1005-1025. PubMed ID: 30599067
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
    Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
    Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Effect of silencing the T‑Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells.
    Du WL; Fang Q; Chen Y; Teng JW; Xiao YS; Xie P; Jin B; Wang JQ
    Mol Med Rep; 2017 Nov; 16(5):6050-6058. PubMed ID: 28849151
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
    Avior Y; Lezmi E; Yanuka D; Benvenisty N
    Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.